Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20430647rdf:typepubmed:Citationlld:pubmed
pubmed-article:20430647lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:20430647lifeskim:mentionsumls-concept:C0003483lld:lifeskim
pubmed-article:20430647lifeskim:mentionsumls-concept:C0020672lld:lifeskim
pubmed-article:20430647lifeskim:mentionsumls-concept:C0456388lld:lifeskim
pubmed-article:20430647lifeskim:mentionsumls-concept:C0003641lld:lifeskim
pubmed-article:20430647lifeskim:mentionsumls-concept:C0040613lld:lifeskim
pubmed-article:20430647lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:20430647lifeskim:mentionsumls-concept:C0534191lld:lifeskim
pubmed-article:20430647lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:20430647lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:20430647lifeskim:mentionsumls-concept:C0237477lld:lifeskim
pubmed-article:20430647lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:20430647pubmed:issue6lld:pubmed
pubmed-article:20430647pubmed:dateCreated2010-11-26lld:pubmed
pubmed-article:20430647pubmed:abstractTextAprotinin, once used to reduce allogeneic blood product transfusion during cardiac surgery, was withdrawn from the market in late 2007 over concerns of causing increased mortality. This study was undertaken to determine what, if any, the impact of changing antifibrinolytic agents (from aprotinin to tranexamic acid) for deep hypothermic circulatory arrest cases would have on blood bank resource utilization.lld:pubmed
pubmed-article:20430647pubmed:languageenglld:pubmed
pubmed-article:20430647pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20430647pubmed:citationSubsetIMlld:pubmed
pubmed-article:20430647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20430647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20430647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20430647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20430647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20430647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20430647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20430647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20430647pubmed:statusMEDLINElld:pubmed
pubmed-article:20430647pubmed:monthDeclld:pubmed
pubmed-article:20430647pubmed:issn1532-8422lld:pubmed
pubmed-article:20430647pubmed:authorpubmed-author:ChenEdward...lld:pubmed
pubmed-article:20430647pubmed:authorpubmed-author:KikuraMutsuhi...lld:pubmed
pubmed-article:20430647pubmed:authorpubmed-author:TanakaKenichi...lld:pubmed
pubmed-article:20430647pubmed:authorpubmed-author:SniecinskiRom...lld:pubmed
pubmed-article:20430647pubmed:authorpubmed-author:BolligerDanie...lld:pubmed
pubmed-article:20430647pubmed:authorpubmed-author:MakadiaSunal...lld:pubmed
pubmed-article:20430647pubmed:copyrightInfoCopyright © 2010 Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:20430647pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20430647pubmed:volume24lld:pubmed
pubmed-article:20430647pubmed:ownerNLMlld:pubmed
pubmed-article:20430647pubmed:authorsCompleteYlld:pubmed
pubmed-article:20430647pubmed:pagination959-63lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:meshHeadingpubmed-meshheading:20430647...lld:pubmed
pubmed-article:20430647pubmed:year2010lld:pubmed
pubmed-article:20430647pubmed:articleTitleChanging from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest.lld:pubmed
pubmed-article:20430647pubmed:affiliationDepartment of Anesthesiology, Emory University School of Medicine, Atlanta, GA 30322, USA. roman.sniecinski@emory.edulld:pubmed
pubmed-article:20430647pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20430647pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed